Solara Active Pharma Sciences Limited (SOLARA.BO)
INR 509.6
(3.02%)
INR 509.6
(3.02%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -2.82 Billion INR | -239.33% |
| 2022 | 1.52 Billion INR | 56.48% |
| 2021 | 885 Million INR | -75.5% |
| 2020 | 4.13 Billion INR | 50.9% |
| 2019 | 2.85 Billion INR | 20.45% |
| 2018 | 2.32 Billion INR | 256.62% |
| 2017 | 626.33 Million INR | -49.69% |
| 2016 | 1.22 Billion INR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 419.2 Million INR | 138.37% |
| 2024 Q2 | 616.3 Million INR | 45.08% |
| 2023 Q4 | -1.13 Billion INR | 29.89% |
| 2023 Q1 | 211.6 Million INR | -60.41% |
| 2023 Q2 | 388.1 Million INR | 83.41% |
| 2023 FY | - INR | -239.33% |
| 2023 Q3 | -1.61 Billion INR | -515.46% |
| 2022 Q2 | 312.9 Million INR | 60.22% |
| 2022 Q4 | 534.5 Million INR | 2.45% |
| 2022 FY | - INR | 56.48% |
| 2022 Q1 | 195.3 Million INR | -19.36% |
| 2022 Q3 | 521.7 Million INR | 66.73% |
| 2021 Q4 | 242.2 Million INR | 126.74% |
| 2021 FY | - INR | -75.5% |
| 2021 Q3 | -905.9 Million INR | -220.39% |
| 2021 Q2 | 752.5 Million INR | -22.69% |
| 2021 Q1 | 973.3 Million INR | -6.99% |
| 2020 FY | - INR | 50.9% |
| 2020 Q2 | 1.03 Billion INR | 17.38% |
| 2020 Q1 | 883.8 Million INR | 70.06% |
| 2020 Q3 | 1.13 Billion INR | 9.53% |
| 2020 Q4 | 1.04 Billion INR | -7.9% |
| 2019 Q4 | 519.7 Million INR | -37.94% |
| 2019 FY | - INR | 20.45% |
| 2019 Q3 | 837.4 Million INR | 14.76% |
| 2019 Q2 | 729.7 Million INR | 7.25% |
| 2019 Q1 | 680.4 Million INR | 9.84% |
| 2018 Q4 | 619.45 Million INR | -5.93% |
| 2018 FY | - INR | 256.62% |
| 2018 Q1 | 465.8 Million INR | 39.8% |
| 2018 Q2 | 494.9 Million INR | 6.25% |
| 2018 Q3 | 658.5 Million INR | 33.06% |
| 2017 Q4 | 333.18 Million INR | 0.0% |
| 2017 Q2 | 88.48 Million INR | -75.76% |
| 2017 Q1 | 364.98 Million INR | 0.0% |
| 2017 FY | - INR | -49.69% |
| 2016 FY | - INR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 9.61 Billion INR | 129.344% |
| Aurobindo Pharma Limited | 61.78 Billion INR | 104.567% |
| Glenmark Life Sciences Limited | 6.86 Billion INR | 141.118% |
| Granules India Limited | 8.6 Billion INR | 132.798% |
| Indoco Remedies Limited | 2.64 Billion INR | 206.605% |
| Achyut Healthcare Limited | 524 Thousand INR | 538630.534% |
| Ajanta Pharma Limited | 12.56 Billion INR | 122.458% |
| Alkem Laboratories Limited | 24.19 Billion INR | 111.663% |
| Alpa Laboratories Limited | 86.12 Million INR | 3376.441% |
| Brooks Laboratories Limited | 41.72 Million INR | 6862.605% |
| AstraZeneca Pharma India Limited | 2.35 Billion INR | 219.734% |
| Bajaj HealthCare Limited | 444.51 Million INR | 734.825% |
| Bliss GVS Pharma Limited | 1.47 Billion INR | 290.794% |
| Dr. Reddy's Laboratories Limited | 88.27 Billion INR | 103.197% |
| Eris Lifesciences Limited | 6.98 Billion INR | 140.391% |
| FDC Limited | 4.4 Billion INR | 164.109% |
| Glenmark Pharmaceuticals Limited | 11.34 Billion INR | 124.876% |
| Gufic Biosciences Limited | 1.48 Billion INR | 290.606% |
| Ind-Swift Laboratories Limited | 6.86 Billion INR | 141.126% |
| Ipca Laboratories Limited | 13.29 Billion INR | 121.218% |
| Jagsonpal Pharmaceuticals Limited | 323.46 Million INR | 972.411% |
| Krebs Biochemicals & Industries Limited | -82.72 Million INR | -3311.099% |
| Lasa Supergenerics Limited | -65.08 Million INR | -4236.048% |
| Laurus Labs Limited | 8 Billion INR | 135.247% |
| Lupin Limited | 36.96 Billion INR | 107.633% |
| Mankind Pharma Limited | 28.09 Billion INR | 110.044% |
| Medicamen Biotech Limited | 245.66 Million INR | 1248.701% |
| Medico Remedies Limited | 150.37 Million INR | 1976.538% |
| Megasoft Limited | 284.73 Million INR | 1091.076% |
| NATCO Pharma Limited | 18.79 Billion INR | 115.014% |
| Piramal Pharma Limited | 13.05 Billion INR | 121.615% |
| RPG Life Sciences Limited | 1.28 Billion INR | 320.203% |
| Sigachi Industries Limited | 883.39 Million INR | 419.437% |
| Sun Pharmaceutical Industries Limited | 138.36 Billion INR | 102.039% |
| Suven Pharmaceuticals Limited | 4.67 Billion INR | 160.333% |
| Syncom Formulations (India) Limited | 430.27 Million INR | 755.835% |
| Unichem Laboratories Limited | 742.35 Million INR | 480.128% |
| Wanbury Limited | 985.49 Million INR | 386.345% |
| Windlas Biotech Limited | 781.72 Million INR | 460.986% |
| ZIM Laboratories Limited | 462.09 Million INR | 710.673% |
| Zydus Lifesciences Limited | 56.22 Billion INR | 105.019% |
| Sun Pharma Advanced Research Company Limited | -3.73 Billion INR | 24.372% |
| Divi's Laboratories Limited | 25.43 Billion INR | 111.097% |
| Hester Biosciences Limited | 539.47 Million INR | 623.087% |
| Procter & Gamble Health Limited | 3.01 Billion INR | 193.614% |
| Amrutanjan Health Care Limited | 682.53 Million INR | 513.442% |
| Bal Pharma Limited | 345.59 Million INR | 916.541% |
| Strides Pharma Science Limited | 3.76 Billion INR | 174.957% |
| Venus Remedies Limited | 711.8 Million INR | 496.445% |
| Aarti Pharmalabs Limited | 3.9 Billion INR | 172.182% |
| Nectar Lifesciences Limited | 1.56 Billion INR | 280.453% |
| Shilpa Medicare Limited | 2.58 Billion INR | 209.039% |
| Aarti Drugs Limited | 3.24 Billion INR | 186.864% |
| IOL Chemicals and Pharmaceuticals Limited | 2.6 Billion INR | 208.26% |
| Suven Life Sciences Limited | -992.78 Million INR | -184.242% |
| Ind-Swift Limited | 1.06 Billion INR | 364.951% |
| Valiant Laboratories Limited | 12.73 Million INR | 22251.66% |
| J. B. Chemicals & Pharmaceuticals Limited | 9.33 Billion INR | 130.23% |
| Themis Medicare Limited | 562.6 Million INR | 601.576% |
| Hikal Limited | 2.69 Billion INR | 204.816% |
| Torrent Pharmaceuticals Limited | 35 Billion INR | 108.06% |
| Sequent Scientific Limited | 549.8 Million INR | 613.259% |
| Novartis India Limited | 1.26 Billion INR | 322.319% |
| Wockhardt Limited | 1.08 Billion INR | 361.287% |
| Jubilant Pharmova Limited | 8 Billion INR | 135.247% |
| Biofil Chemicals and Pharmaceuticals Limited | 13.06 Million INR | 21703.889% |
| Neuland Laboratories Limited | 4.74 Billion INR | 159.431% |
| Morepen Laboratories Limited | 1.72 Billion INR | 263.498% |
| Kilitch Drugs (India) Limited | 287.42 Million INR | 1081.787% |
| Mangalam Drugs & Organics Limited | 174.94 Million INR | 1713.012% |